| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09:15 | Shortseller-Positionen aktuell: u.a. Auto1, Carl Zeiss Meditec, Evotec, Kontron, Puma, Renk, Verve, Zalando | 1.560 | 4investors | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| 07:03 | Adhoc: BioVersys AG: BioVersys announces first patient first visit in HABP/VABP pivotal Phase 3 RIV-TARGET trial of BV100 | 776 | EQS Group (EN) | BioVersys AG / Key word(s): Study
BioVersys announces first patient first visit in HABP/VABP pivotal Phase 3 RIV-TARGET trial of BV100 16-Apr-2026 / 07:00 CET/CEST
Release of an ad hoc... ► Artikel lesen | |
| 08:26 | Faron Pharmaceuticals: Faron Announces Collaboration with Parexel to Support Phase IIb BEXERA Trial in Treatment-Naïve HR-MDS | 617 | ACCESS Newswire | Strategic collaboration with a leading global CRO supports disciplined trial execution and operational efficiency, advancing Faron's mission to provide treatment for patients with HR-MDS TURKU, FI /... ► Artikel lesen | |
| 13:26 | Resverlogix Corp.: Resverlogix Corp. Announces Filing of Annual Filings and Revocation of MCTO | 321 | Newsfile | Calgary, Alberta--(Newsfile Corp. - April 16, 2026) - Resverlogix Corp. (TSX: RVX) ("Resverlogix" or the "Company") announces the revocation, effective April 15, 2026, of a management cease trade... ► Artikel lesen | |
| Mi | EQS-News: GeoVax, Inc.: GeoVax Reports 2025 Year-End Financial Results and Provides Business Update | 303 | EQS Group (EN) | EQS-News: GeoVax, Inc.
/ Key word(s): Financial
GeoVax Reports 2025 Year-End Financial Results and Provides Business Update 15.04.2026 / 22:13 CET/CEST
The issuer is solely... ► Artikel lesen | |
| 07:34 | Bavarian Nordic A/S: Bavarian Nordic Receives Swissmedic Approval for Chikungunya Vaccine | 292 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, April 16, 2026 - Bavarian Nordic A/S (OMX: BAVA) today announced that the Swiss Agency for Therapeutic Products, Swissmedic, has approved VIMKUNYA (recombinant, adsorbed) for active... ► Artikel lesen | |
| 08:00 | NurExone Aufbruch in den US-Markt für Exosomen | Small- & Micro Cap Investment | |||
| 18:06 | Medincell to Host an Online R&D Day on Tuesday, May 12, 2026 | 258 | Business Wire | > From Science to Long-Term Value Creation
Regulatory News:
Medincell (Euronext Paris: MEDCL) will host an online R&D Day, held in English, on Tuesday, May 12, 2026, from 4:00 to 5:30 pm CEST... ► Artikel lesen | |
| 13:22 | Tiziana Life Sciences Ltd.: Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function | 246 | GlobeNewswire (Europe) | Data from independent academic collaborators published on bioRxiv support the therapeutic potential of the Company's lead candidate, intranasal foralumab, for Long COVID associated "brain fog".BOSTON... ► Artikel lesen | |
| 13:26 | OS Therapies: OS Therapies Files New Patent Application Covering Biomarkers of the Immune Response to Listeria Monocytogenes | 239 | Newsfile | New patent application covers treatment-emergent immune signature related to 'turning cold tumors hot' and the activation of targeted cytotoxic cellular immune responses Company to host conference... ► Artikel lesen | |
| 13:06 | Alkermes plc: Alkermes to Present Additional Data From Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at the American Academy of Neurology (AAN) 2026 Annual Meeting | 229 | Business Wire | - Alixorexton Data From Seven-Week Open-Label Extension Period Demonstrated Sustained Improvements in Patient-Reported Disease Severity, Cognitive Functioning and Fatigue- - Alixorexton Was Generally... ► Artikel lesen | |
| 14:06 | Bio-Techne Corporation: Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity | 213 | PR Newswire | Bio-Techne introduces a streamlined brand architecture that organizes its technologies into three focused portfolio brands: R&D Systems, Bio-Techne Spatial, and Bio-Techne Diagnostics.The... ► Artikel lesen | |
| 14:06 | Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026 | 206 | PR Newswire | SAN DIEGO and NEW YORK, April 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, today announced that the Mount Sinai Health System... ► Artikel lesen | |
| 08:26 | Biovica International: Theis Kipling to Assume Role as CEO of Biovica on May 1, 2026 | 201 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 16, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica today announces that Theis Kipling will assume the role as Chief Executive Officer... ► Artikel lesen | |
| 13:02 | Microbix Biosystems Inc.: Microbix Presenting at the 2026 Bloom Burton Conference | 192 | ACCESS Newswire | MISSISSAUGA, ON / ACCESS Newswire / April 16, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix), a life sciences innovator, manufacturer, and exporter, announces it will be attending... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
|---|---|---|---|---|---|---|
| BB BIOTECH | 49,950 | 2,47 | +4,94 % | 2,25 | 23.03.2026 | |
| CSL | 83,79 | 2,61 | +3,11 % | 1,84 | 10.03.2026 | |
| AMGEN | 295,80 | 8,27 | +2,80 % | 2,52 | 15.05.2026 | |
| RECORDATI | 50,10 | 1,30 | +2,59 % | 0,71 | 18.05.2026 | |
| NOVONESIS | 50,48 | 0,87 | +1,72 % | 4,25 | 20.03.2026 | |
| SINO BIOPHARM | 0,658 | 0,01 | +1,52 % | 0,05 | 24.06.2026 | |
| GENUS | 30,400 | 0,38 | +1,25 % | 0,11 | 05.03.2026 | |
| 3SBIO | 2,651 | 0,03 | +1,13 % | 0,25 | 21.07.2026 | |
| VITROLIFE | 9,930 | 0,10 | +1,01 % | 1,10 | 06.05.2026 | |
| BIOMERIEUX | 93,50 | 0,90 | +0,96 % | 0,98 | 09.06.2026 |